What Researchers Did
Researchers conducted a prospective, double-blinded study involving 64 parturients undergoing elective caesarean delivery to determine the median effective dose (ED50) of intrathecal hyperbaric ropivacaine with and without sufentanil.
What They Found
They found that the ED50 of intrathecal ropivacaine was 11.2 mg (95% CI: 11.0-11.6) without sufentanil, compared to 8.1 mg (95% CI: 7.8-8.3) when coadministered with 5 microg sufentanil. Patients receiving sufentanil experienced markedly less intense motor block and a lower incidence of shivering.
What This Means for Canadian Patients
For Canadian patients undergoing caesarean delivery, adding sufentanil to intrathecal ropivacaine could allow for a lower dose of local anesthetic. This may lead to less intense motor block and reduced shivering during the procedure.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or by Canadian researchers.
Study Limitations
A limitation of this study is its focus on elective caesarean deliveries, which may not be generalizable to all obstetric patients, and the short-term nature of the assessed outcomes.